Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer

Summary

Current therapies for Recurrent or Stage IV Lung Cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Recurrent or Stage IV Lung Cancer. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Recurrent or Stage IV Lung Cancer.

Timeline

Start

1996-03-26

Primary completion

2002-05-26

Completion

2002-05-26

Drugs

Indications